| Bioactivity | Tifalibep (ABY-039) is a small protein ligand. Tifalibep distinguishes competing antibodies by binding to albumin and FcRn.Tifalibep inhibits IgG-FcRn interaction and to lower IgG levels[1]. |
| Name | Tifalibep |
| CAS | 2226130-04-5 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zuercher AW, et, al. Next-generation Fc receptor-targeting biologics for autoimmune diseases. Autoimmun Rev. 2019 Oct;18(10):102366. |